Performance Package: IGF-1 LR3 (1mg)

For research use only. Not for human consumption. Not a TGA-registered therapeutic good. The Performance Package features IGF-1 LR3 – a long-acting analogue of Insulin-like Growth Factor 1 studied extensively in preclinical research on anabolic signalling, cellular proliferation, and tissue repair. The LR3 variant incorporates an arginine substitution at position 3 and an N-terminal 13-amino acid extension, resulting in significantly reduced IGF-binding protein affinity and extended biological activity compared to native IGF-1. Compound Profile IGF-1 LR3 – Extended-Action IGF-1 Analogue: Preclinical studies report significantly longer half-life compared to native IGF-1, with sustained signalling through the IGF-1 receptor (IGF1R) – involved in PI3K/Akt and MAPK pathway activation in cell culture and in vivo models. Research applications include myocyte proliferation, satellite cell activation in skeletal muscle models, adipocyte differentiation, and neuronal survival signalling. Contents Component Size Purity IGF-1 LR3 1mg 99%+ HPLC Lyophilised powder, HPLC verified. Certificate of Analysis available on request. Reconstitution Guidelines Reconstitute with bacteriostatic water or 0.6% acetic acid. Recommended: 0.1mg/ml. Use our Peptide Reconstitution Calculator Storage Lyophilised: 2-8C, protected from light | Reconstituted: 2-8C, use within 28 days | Long-term: -20C Verify Our Beligas Authorisation AU Supplement Co is an authorised Beligas reseller. Verify at beligas.org/verify-distributors. For research use only. Not for human consumption. Not a TGA-registered therapeutic good.